national stem-cell therapy logo

Seraxis Announces Appointment of Chief Medical Officer, Dr. Paul Strumph

Dr Paul Strumph

GERMANTOWN, Md., Aug. 30, 2022 (GLOBE NEWSWIRE) — The regenerative medicine company Seraxis Inc. today announced the appointment of Paul Strumph, M.D. as Chief Medical Officer. Dr. Strumph is an endocrinology and diabetes care and research specialist with a successful career of bringing anti-diabetes treatments to market. He will drive the company’s clinical and medical […]